These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Development of andrographolide loaded PLGA microspheres: optimization, characterization and in vitro-in vivo correlation. Jiang Y, Wang F, Xu H, Liu H, Meng Q, Liu W. Int J Pharm; 2014 Nov 20; 475(1-2):475-84. PubMed ID: 25219858 [Abstract] [Full Text] [Related]
5. PLGA microdevices for retinoids sustained release produced by supercritical emulsion extraction: continuous versus batch operation layouts. Porta GD, Campardelli R, Falco N, Reverchon E. J Pharm Sci; 2011 Oct 20; 100(10):4357-67. PubMed ID: 21638283 [Abstract] [Full Text] [Related]
6. Preparation of rifampicin-loaded PLGA microspheres for lung delivery as aerosol by premix membrane homogenization. Doan TV, Olivier JC. Int J Pharm; 2009 Dec 01; 382(1-2):61-6. PubMed ID: 19682562 [Abstract] [Full Text] [Related]
7. Development of near zero-order release PLGA-based microspheres of a novel antipsychotic. Zhao J, Wang L, Fan C, Yu K, Liu X, Zhao X, Wang D, Liu W, Su Z, Sun F, Li Y. Int J Pharm; 2017 Jan 10; 516(1-2):32-38. PubMed ID: 27825865 [Abstract] [Full Text] [Related]
8. Preparation of ONO-1301-loaded poly(lactide-co-glycolide) microspheres and their effect on nerve conduction velocity. Hazekawa M, Sakai Y, Yoshida M, Haraguchi T, Morisaki T, Uchida T. J Pharm Pharmacol; 2011 Mar 10; 63(3):362-8. PubMed ID: 21749383 [Abstract] [Full Text] [Related]
9. Microsphere delivery of Risperidone as an alternative to combination therapy. D'Souza S, Faraj J, DeLuca P. Eur J Pharm Biopharm; 2013 Nov 10; 85(3 Pt A):631-9. PubMed ID: 23892159 [Abstract] [Full Text] [Related]
10. Preparation and in vitro and in vivo evaluation of HupA PLGA microsphere. Ye L, Fu F, Liu W, Sun K, Li Y, He J, Yu X, Yu P, Tian J. Pak J Pharm Sci; 2013 Mar 10; 26(2):315-22. PubMed ID: 23455202 [Abstract] [Full Text] [Related]
13. Pharmacokinetics and in vitro and in vivo correlation of huperzine A loaded poly(lactic-co-glycolic acid) microspheres in dogs. Chu DF, Fu XQ, Liu WH, Liu K, Li YX. Int J Pharm; 2006 Nov 15; 325(1-2):116-23. PubMed ID: 16876971 [Abstract] [Full Text] [Related]
14. Doxorubicin-loaded poly(lactic-co-glycolic acid) microspheres prepared using the solid-in-oil-in-water method for the transarterial chemoembolization of a liver tumor. Choi JW, Park JH, Baek SY, Kim DD, Kim HC, Cho HJ. Colloids Surf B Biointerfaces; 2015 Aug 01; 132():305-12. PubMed ID: 26057730 [Abstract] [Full Text] [Related]
15. Insulin loaded PLGA microspheres: effect of zinc salts on encapsulation, release, and stability. Manoharan C, Singh J. J Pharm Sci; 2009 Feb 01; 98(2):529-42. PubMed ID: 18548615 [Abstract] [Full Text] [Related]
16. Sustained-release delivery of octreotide from biodegradable polymeric microspheres. Rhee YS, Sohn M, Woo BH, Thanoo BC, DeLuca PP, Mansour HM. AAPS PharmSciTech; 2011 Dec 01; 12(4):1293-301. PubMed ID: 21948321 [Abstract] [Full Text] [Related]
17. Stabilization and encapsulation of a staphylokinase variant (K35R) into poly(lactic-co-glycolic acid) microspheres. He JT, Su HB, Li GP, Tao XM, Mo W, Song HY. Int J Pharm; 2006 Feb 17; 309(1-2):101-8. PubMed ID: 16413979 [Abstract] [Full Text] [Related]
20. The angiogenic effect of ONO-1301, a novel long-acting prostacyclin agonist loaded in PLGA microspheres prepared using different molecular weights of PLGA, in a murine sponge model. Hazekawa M, Morihata K, Yoshida M, Sakai Y, Uchida T. Drug Dev Ind Pharm; 2014 Nov 17; 40(11):1435-42. PubMed ID: 23937583 [Abstract] [Full Text] [Related] Page: [Next] [New Search]